AdvisorShares Psychedelics ETF Rating $13.92 -0.10 (-0.71%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$14.61 +0.69 (+4.95%) As of 06/13/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingBuy 3.01Holdings in PSIL have an aggregate rating of Buy based on 94 analyst ratings issued in the past year covering 13 companies (74.2% of the portfolio).PSIL Aggregate Price Target$13.92High Prediction$13.92Average Prediction$13.92Low Prediction$13.92Holdings in PSIL have an aggregate price target of $13.92 and a range of $13.92 to $13.92 covering 13 companies (74.2% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy3 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 13 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.08%MNMDMind Medicine (MindMed)$7.17-1.8%1.9112 of 5 stars3.27$25.50 255.6%11Positive NewsGap Down8.91%ATAIAtai Life Sciences$2.11-3.2%3.287 of 5 stars3.33$8.67 310.7%3Gap Down8.12%NRXPNRx Pharmaceuticals$3.442.3293 of 5 stars3.20$28.50 728.5%5Positive NewsGap Down7.64%CMPSCOMPASS Pathways$4.39-2.9%2.4902 of 5 stars3.00$18.83 329.0%6Positive NewsGap Up6.45%STIMNeuronetics$3.79-0.5%1.9556 of 5 stars2.67$5.50 45.1%36.10%ALKSAlkermes$29.83-3.1%4.6849 of 5 stars2.77$38.85 30.2%135.68%SAGESage Therapeutics$6.70+1.5%3.5799 of 5 stars2.06$8.87 32.3%174.90%NEUPNeuphoria Therapeutics Inc. - Common Stock$6.82-4.5%1.992 of 5 stars3.00$21.00 207.9%1Gap Up4.79%GHRSGH Research$12.76-0.5%1.7712 of 5 stars3.00$32.00 150.8%74.51%VTGNVistagen Therapeutics$2.21-4.7%1.0373 of 5 stars4.0014.46%NBIXNeurocrine Biosciences$124.39-0.5%4.9097 of 5 stars2.86$162.00 30.2%22Positive News2.17%RLMDRelmada Therapeutics$0.70-0.8%4.7933 of 5 stars2.25$5.00 614.1%4Positive NewsGap Down1.39%ENVBEnveric Biosciences$1.21-2.4%2.0367 of 5 stars3.00$10.00 726.4%1Short Interest ↑Gap Down This page (NYSEARCA:PSIL) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
